Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. More Details
Reasonable growth potential with imperfect balance sheet.
Share Price & News
How has Core Laboratories's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: CLB is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 12% a week.
Volatility Over Time: CLB's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.
7 Day Return
US Energy Services
1 Year Return
US Energy Services
Return vs Industry: CLB underperformed the US Energy Services industry which returned -32% over the past year.
Return vs Market: CLB underperformed the US Market which returned 22.1% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Core Laboratories's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 days ago | Simply Wall StCore Laboratories (NYSE:CLB) Has A Somewhat Strained Balance Sheet
3 weeks ago | Simply Wall StHave Insiders Been Buying Core Laboratories N.V. (NYSE:CLB) Shares?
1 month ago | Simply Wall StCalculating The Intrinsic Value Of Core Laboratories N.V. (NYSE:CLB)
Is Core Laboratories undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: CLB ($26.67) is trading below our estimate of fair value ($29.78)
Significantly Below Fair Value: CLB is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: CLB is unprofitable, so we can't compare its PE Ratio to the US Energy Services industry average.
PE vs Market: CLB is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate CLB's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: CLB is overvalued based on its PB Ratio (17.5x) compared to the US Energy Services industry average (0.6x).
How is Core Laboratories forecast to perform in the next 1 to 3 years based on estimates from 13 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CLB is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.2%).
Earnings vs Market: CLB is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: CLB's is expected to become profitable in the next 3 years.
Revenue vs Market: CLB's revenue (6.7% per year) is forecast to grow slower than the US market (10.2% per year).
High Growth Revenue: CLB's revenue (6.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CLB's Return on Equity is forecast to be high in 3 years time (34.9%)
How has Core Laboratories performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CLB is currently unprofitable.
Growing Profit Margin: CLB is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: CLB is unprofitable, and losses have increased over the past 5 years at a rate of 30% per year.
Accelerating Growth: Unable to compare CLB's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CLB is unprofitable, making it difficult to compare its past year earnings growth to the Energy Services industry (-34.7%).
Return on Equity
High ROE: CLB has a negative Return on Equity (-140.47%), as it is currently unprofitable.
How is Core Laboratories's financial position?
Financial Position Analysis
Short Term Liabilities: CLB's short term assets ($169.9M) do not cover its short term liabilities ($172.1M).
Long Term Liabilities: CLB's short term assets ($169.9M) do not cover its long term liabilities ($347.0M).
Debt to Equity History and Analysis
Debt Level: CLB's debt to equity ratio (373.4%) is considered high.
Reducing Debt: CLB had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Debt Coverage: CLB's debt is well covered by operating cash flow (34%).
Interest Coverage: CLB is unprofitable, therefore interest payments are not well covered by earnings.
What is Core Laboratories's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: CLB's dividend (0.15%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.49%).
High Dividend: CLB's dividend (0.15%) is low compared to the top 25% of dividend payers in the US market (4.1%).
Stability and Growth of Payments
Stable Dividend: CLB is not paying a notable dividend for the US market, therefore no need to check if payments are stable.
Growing Dividend: CLB is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: CLB is not paying a notable dividend for the US market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of CLB's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Larry Bruno (60 yo)
Mr. Lawrence V. Bruno, also known as Larry, serves as Chairman of Supervisory Board and Chief Exertive Officer at Core Laboratories N.V. since May 20, 2020. He has been Supervisory Director of Core Laborat...
CEO Compensation Analysis
Compensation vs Market: Larry's total compensation ($USD2.97M) is about average for companies of similar size in the US market ($USD2.60M).
Compensation vs Earnings: Larry's compensation has increased whilst the company is unprofitable.
|Chairman of the Board||0.58yr||US$2.97m||0.024% |
|Senior VP & CFO||2.58yrs||US$1.09m||0.034% |
|Executive Officer||0.58yr||US$11.18m||1.56% |
|Chief Accounting Officer||2.5yrs||no data||0.0018% |
|Senior Vice President of Corporate Development & Investor Relations||4.33yrs||no data||no data|
|Senior VP||12.75yrs||no data||0.071% |
|Managing Director||no data||US$174.34k||no data|
|Senior VP of Production Enhancement & Business Development||0.92yr||no data||no data|
Experienced Management: CLB's management team is considered experienced (2.5 years average tenure).
|Chairman of the Board||0.58yr||US$2.97m||0.024% |
|Independent Supervisory Director||0.58yr||no data||0.0045% |
|Independent Supervisory Director||4.92yrs||US$258.14k||0.0077% |
|Lead Independent Director||0.58yr||US$258.21k||0.014% |
|Independent Supervisory Director||8.58yrs||US$236.34k||0.012% |
|Independent Supervisory Director||1.58yrs||US$119.14k||0.034% |
|Independent Supervisory Director||0.58yr||no data||no data|
Experienced Board: CLB's board of directors are not considered experienced ( 0.6 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Core Laboratories N.V.'s company bio, employee growth, exchange listings and data sources
- Name: Core Laboratories N.V.
- Ticker: CLB
- Exchange: NYSE
- Founded: 1936
- Industry: Oil and Gas Equipment and Services
- Sector: Energy
- Market Cap: US$1.187b
- Shares outstanding: 44.49m
- Website: https://www.corelab.com
Number of Employees
- Core Laboratories N.V.
- Tower A
- Level 9
- 1077 XX
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|CLB||NYSE (New York Stock Exchange)||Yes||Common Shares||US||USD||Sep 1995|
|CEI||DB (Deutsche Boerse AG)||Yes||Common Shares||DE||EUR||Sep 1995|
|CLB||ENXTAM (Euronext Amsterdam)||Yes||Common Shares||NL||EUR||Sep 1995|
|0Q82||LSE (London Stock Exchange)||Yes||Common Shares||GB||EUR||Sep 1995|
|CLBA||BATS-CHIXE (BATS 'Chi-X Europe')||Yes||Common Shares||GB||EUR||Sep 1995|
|CLB N||BMV (Bolsa Mexicana de Valores)||Yes||Common Shares||MX||MXN||Sep 1995|
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/12/05 00:33|
|End of Day Share Price||2020/12/04 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.